These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 29998019)

  • 1. Non-surgical management of patients with intrahepatic cholangiocarcinoma in the United States, 2004-2015: an NCDB analysis.
    Kolarich AR; Shah JL; George TJ; Hughes SJ; Shaw CM; Geller BS; Grajo JR
    J Gastrointest Oncol; 2018 Jun; 9(3):536-545. PubMed ID: 29998019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential survival benefit of radiofrequency ablation for small solitary intrahepatic cholangiocarcinoma in nonsurgically managed patients: A population-based analysis.
    Wu L; Tsilimigras DI; Farooq A; Hyer JM; Merath K; Paredes AZ; Mehta R; Sahara K; Shen F; Pawlik TM
    J Surg Oncol; 2019 Dec; 120(8):1358-1364. PubMed ID: 31614000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiofrequency Ablation vs. Surgical Resection for Small Early-Stage Primary Intrahepatic Cholangiocarcinoma.
    Xiang X; Hu D; Jin Z; Liu P; Lin H
    Front Oncol; 2020; 10():540662. PubMed ID: 33134161
    [No Abstract]   [Full Text] [Related]  

  • 4. Increasing age predicts poor cervical cancer prognosis with subsequent effect on treatment and overall survival.
    Quinn BA; Deng X; Colton A; Bandyopadhyay D; Carter JS; Fields EC
    Brachytherapy; 2019; 18(1):29-37. PubMed ID: 30361045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination of intraoperative radiofrequency ablation and surgical resection for treatment of cholangiocarcinoma: feasibility and long-term survival.
    Lee SM; Ko HK; Shin JH; Kim JH; Chu HH
    Diagn Interv Radiol; 2020 Jan; 26(1):45-52. PubMed ID: 31904570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiofrequency ablation versus surgical resection of hepatocellular carcinoma: contemporary treatment trends and outcomes from the United States National Cancer Database.
    Uhlig J; Sellers CM; Stein SM; Kim HS
    Eur Radiol; 2019 May; 29(5):2679-2689. PubMed ID: 30560364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrahepatic Cholangiocarcinoma and Thermal Ablation: Long-term Results of An Italian Retrospective Multicenter Study.
    Giorgio A; Gatti P; Montesarchio L; Santoro B; Dell'Olio A; Crucinio N; Coppola C; Scarano F; Biase F; Ciracì E; Semeraro S; Giorgio V
    J Clin Transl Hepatol; 2019 Dec; 7(4):287-292. PubMed ID: 31915596
    [No Abstract]   [Full Text] [Related]  

  • 8. Radiofrequency ablation for recurrent intrahepatic cholangiocarcinoma after curative resection.
    Kim JH; Won HJ; Shin YM; Kim PN; Lee SG; Hwang S
    Eur J Radiol; 2011 Dec; 80(3):e221-5. PubMed ID: 20950977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ERCP-directed radiofrequency ablation and photodynamic therapy are associated with comparable survival in the treatment of unresectable cholangiocarcinoma.
    Strand DS; Cosgrove ND; Patrie JT; Cox DG; Bauer TW; Adams RB; Mann JA; Sauer BG; Shami VM; Wang AY
    Gastrointest Endosc; 2014 Nov; 80(5):794-804. PubMed ID: 24836747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Facility Type is Associated with Margin Status and Overall Survival of Patients with Resected Intrahepatic Cholangiocarcinoma.
    Lee GC; Gamblin TC; Fong ZV; Ferrone CR; Goyal L; Lillemoe KD; Blaszkowsky LS; Tanabe KK; Qadan M
    Ann Surg Oncol; 2019 Nov; 26(12):4091-4099. PubMed ID: 31368018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemotherapy for Surgically Resected Intrahepatic Cholangiocarcinoma.
    Miura JT; Johnston FM; Tsai S; George B; Thomas J; Eastwood D; Banerjee A; Christians KK; Turaga KK; Pawlik TM; Clark Gamblin T
    Ann Surg Oncol; 2015 Oct; 22(11):3716-23. PubMed ID: 25777092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Percutaneous radiofrequency ablation in intrahepatic cholangiocarcinoma: a retrospective single-center experience.
    Brandi G; Rizzo A; Dall'Olio FG; Felicani C; Ercolani G; Cescon M; Frega G; Tavolari S; Palloni A; De Lorenzo S; Abbati F; Mollica V; Ricci AD; Serra C
    Int J Hyperthermia; 2020; 37(1):479-485. PubMed ID: 32396398
    [No Abstract]   [Full Text] [Related]  

  • 13. Radiofrequency Ablation Versus Stereotactic Body Radiotherapy for Localized Hepatocellular Carcinoma in Nonsurgically Managed Patients: Analysis of the National Cancer Database.
    Rajyaguru DJ; Borgert AJ; Smith AL; Thomes RM; Conway PD; Halfdanarson TR; Truty MJ; Kurup AN; Go RS
    J Clin Oncol; 2018 Feb; 36(6):600-608. PubMed ID: 29328861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic Factors and Treatment Strategies for Intrahepatic Cholangiocarcinoma from 2004 to 2013: Population-Based SEER Analysis.
    Liu J; Zhong M; Feng Y; Zeng S; Wang Y; Xu H; Zhou H
    Transl Oncol; 2019 Nov; 12(11):1496-1503. PubMed ID: 31446308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intrahepatic Cholangiocarcinoma: Socioeconomic Discrepancies, Contemporary Treatment Approaches and Survival Trends from the National Cancer Database.
    Uhlig J; Sellers CM; Cha C; Khan SA; Lacy J; Stein SM; Kim HS
    Ann Surg Oncol; 2019 Jul; 26(7):1993-2000. PubMed ID: 30693451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Percutaneous Radiofrequency Ablation for Recurrent Intrahepatic Cholangiocarcinoma After Curative Resection: Multivariable Analysis of Factors Predicting Survival Outcomes.
    Chu HH; Kim JH; Shin YM; Won HJ; Kim PN
    AJR Am J Roentgenol; 2021 Aug; 217(2):426-432. PubMed ID: 34076458
    [No Abstract]   [Full Text] [Related]  

  • 17. Radiofrequency ablation
    Conticchio M; Inchingolo R; Delvecchio A; Laera L; Ratti F; Gelli M; Anelli F; Laurent A; Vitali G; Magistri P; Assirati G; Felli E; Wakabayashi T; Pessaux P; Piardi T; di Benedetto F; de'Angelis N; Briceño J; Rampoldi A; Adam R; Cherqui D; Aldrighetti LA; Memeo R
    World J Gastroenterol; 2021 May; 27(18):2205-2218. PubMed ID: 34025074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. No-touch multibipolar radiofrequency ablation vs. surgical resection for solitary hepatocellular carcinoma ranging from 2 to 5 cm.
    Mohkam K; Dumont PN; Manichon AF; Jouvet JC; Boussel L; Merle P; Ducerf C; Lesurtel M; Rode A; Mabrut JY
    J Hepatol; 2018 Jun; 68(6):1172-1180. PubMed ID: 29410287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proton beam radiotherapy vs. radiofrequency ablation for recurrent hepatocellular carcinoma: A randomized phase III trial.
    Kim TH; Koh YH; Kim BH; Kim MJ; Lee JH; Park B; Park JW
    J Hepatol; 2021 Mar; 74(3):603-612. PubMed ID: 33031846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes for Patients with Recurrent Intrahepatic Cholangiocarcinoma After Surgery.
    Park HM; Yun SP; Lee EC; Lee SD; Han SS; Kim SH; Park SJ
    Ann Surg Oncol; 2016 Dec; 23(13):4392-4400. PubMed ID: 27581609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.